Table 6.
Change in HRV (estimated marginal means).
| Ashwagandha (n = 57) |
Placebo (n = 58) |
p-Value
b
|
Percentage change: Week 0 to week 12 |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Week 0 | Week 12 | p-Value a | Week 0 | Week 12 | p-Value a | Ashwagandha | Placebo | ||
| RMSSD | |||||||||
| Mean | 26.44 | 28.84 | 0.141 | 31.37 | 25.46 | 0.018 | 0.003 | 9.08 | −18.84 |
| SE | 2.425 | 2.6 | 3.04 | 1.65 | |||||
Results (estimated means) are generated from generalized mixed-effects models adjusted for age and BMI.
a
p-Values are generated from repeated measures generalized mixed-effects models adjusted for age and BMI (time effects baseline and week 12).
b
p-Values are generated from repeated measures generalized mixed-effects models adjusted for age and BMI (time × group interaction).